Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.
To examine the mechanism by which moderate weight reduction improves basal and insulin-stimulated rates of glucose metabolism in patients with type 2 diabetes, we used (1)H magnetic resonance spectroscopy to assess intrahepatic lipid (IHL) and intramyocellular lipid (IMCL) content in conjunction with hyperinsulinemic-euglycemic clamps using [6,6-(2)H(2)]glucose to assess rates of glucose production and insulin-stimulated peripheral glucose uptake. Eight obese patients with type 2 diabetes were studied before and after weight stabilization on a moderately hypocaloric very-low-fat diet (3%). The diabetic patients were markedly insulin resistant in both liver and muscle compared with the lean control subjects. These changes were associated with marked increases in IHL (12.2 +/- 3.4 vs. 0.6 +/- 0.1%; P = 0.02) and IMCL (2.0 +/- 0.3 vs. 1.2 +/- 0.1%; P = 0.02) compared with the control subjects. A weight loss of only approximately 8 kg resulted in normalization of fasting plasma glucose concentrations (8.8 +/- 0.5 vs. 6.4 +/- 0.3 mmol/l; P < 0.0005), rates of basal glucose production (193 +/- 7 vs. 153 +/- 10 mg/min; P < 0.0005), and the percentage suppression of hepatic glucose production during the clamp (29 +/- 22 vs. 99 +/- 3%; P = 0.003). These improvements in basal and insulin-stimulated hepatic glucose metabolism were associated with an 81 +/- 4% reduction in IHL (P = 0.0009) but no significant change in insulin-stimulated peripheral glucose uptake or IMCL (2.0 +/- 0.3 vs. 1.9 +/- 0.3%; P = 0.21). In conclusion, these data support the hypothesis that moderate weight loss normalizes fasting hyperglycemia in patients with poorly controlled type 2 diabetes by mobilizing a relatively small pool of IHL, which reverses hepatic insulin resistance and normalizes rates of basal glucose production, independent of any changes in insulin-stimulated peripheral glucose metabolism.
Petersen
Kitt Falk
KF
Yale University School of Medicine, Department of Internal Medicine, 300 Cedar St., S263 TAC, P.O. Box 9812, New Haven, CT 06520-8020, USA. kitt.petersen@yale.edu
Dufour
Sylvie
S
Befroy
Douglas
D
Lehrke
Michael
M
Hendler
Rosa E
RE
Shulman
Gerald I
GI
D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000178:diet therapy* / Q000378:metabolism; D005234:Fatty Liver / Q000178:diet therapy*; D005260:Female; D005943:Gluconeogenesis; D006801:Humans; D006943:Hyperglycemia / Q000178:diet therapy*; D007333:Insulin Resistance; D008099:Liver / Q000378:metabolism; D008112:Liver Glycogen / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D015431:Weight Loss
D008112:Liver Glycogen
J Biol Chem. 2000 Mar 24;275(12):8456-60
10722680
Nature. 1999 Sep 2;401(6748):73-6
10485707
Diabetes. 2000 May;49(5):701-7
10905476
Diabetes. 2000 May;49(5):827-31
10905493
J Clin Invest. 2000 Jul;106(2):171-6
10903330
Diabetes. 2000 Aug;49(8):1367-73
10923639
Nature. 2001 Jan 18;409(6818):307-12
11201732
Diabetologia. 2001 Jan;44(1):48-54
11206411
Diabetes. 2001 Apr;50(4):810-6
11289046
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7522-7
11390966
Trends Endocrinol Metab. 2002 Jan-Feb;13(1):18-23
11750858
J Biol Chem. 2002 Jan 11;277(2):1531-7
11606564
Diabetes. 2002 Mar;51(3):797-802
11872682
Eur J Pharmacol. 2002 Apr 12;440(2-3):213-21
12007537
J Clin Invest. 2002 May;109(10):1345-50
12021250
J Clin Endocrinol Metab. 2002 Jul;87(7):3023-8
12107194
Nat Med. 2002 Nov;8(11):1288-95
12368907
Curr Diab Rep. 2003 Jun;3(3):207-13
12762967
J Biol Chem. 2004 Jul 30;279(31):32345-53
15166226
J Clin Invest. 1970 Apr;49(4):837-48
4986215
J Clin Invest. 1976 Dec;58(6):1407-18
993351
J Clin Invest. 1980 Feb;65(2):496-505
7356691
J Lipid Res. 1983 Jan;24(1):96-9
6833886
J Clin Endocrinol Metab. 1985 Nov;61(5):917-25
4044780
Endocrinology. 1992 Sep;131(3):1165-73
1505458
J Clin Invest. 1992 Oct;90(4):1323-7
1401068
Endocrinology. 1994 Nov;135(5):2279-82
7956951
N Engl J Med. 1996 Feb 1;334(5):292-5
8532024
Am J Physiol. 1996 Jan;270(1 Pt 1):E186-91
8772491
Diabetes. 1997 Jul;46(7):1111-9
9200644
Diabetes. 1997 Nov;46(11):1768-74
9356024
Ann Intern Med. 1998 Feb 1;128(3):176-85
9454525
Am J Physiol. 1999 May;276(5 Pt 1):E977-89
10329993
Diabetes. 2000 Mar;49(3):517-20
10868978